Indivior ex-CEO could face jail time after opioid conviction

The resignation of Indivior chief executive Shaun Thaxter this week was swiftly followed by a guilty plea – and possible prison sentence – after he pleaded guilty in a US feder

Bayer agrees $10 billion-plus deal to settle Roundup cancer ...

German pharma and chemicals group Bayer may finally have put long-running litigation over its weedkiller Roundup in its rear view mirror – but at an eye-watering cost of more t

Litigation-weary J&J pulls Baby Powder talc in North America

Johnson and Johnson has opted to withdraw one its iconic products – talc-based Baby Powder – from sale in the US and Canada.

‘Delusional’ Shkreli refused prison release to fight coronav...

Martin Shkreli, the pharma CEO once branded as America’s most hated man has been denied release from prison after a judge ruled his plan to save the world from coronavirus was “delusional”.

Amarin hit hard as generics loom for fish oil drug Vascepa

UK court imposes safety rules on off-label use of Avastin in...

Bayer has said a new UK court ruling could limit off-label use of Roche's Avastin in ophthalmology by imposing stricter safety and consent measures.